Search
for
Sort by
Research 541–570 of 579
- Natural Sources of Therapeutic Agents Used in Skin Conditions
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Nagashima-Type Palmoplantar Keratosis: A Common Asian Type Caused by SERPINB7 Protease Inhibitor Deficiency
- Progressive Hair Loss and Myocardial Degeneration in Rough Coat Mice: Reduced Lysyl Oxidase-Like (LOXL) in the Skin and Heart
- Disrupted Pancreatic Exocrine Differentiation and Malabsorption in Response to Chronic Elevated Systemic Glucocorticoid
- JAK inhibition decreases the autoimmune burden in Down syndrome
- The immune response to COVID‐19: Does sex matter?
- Under Development JAK Inhibitors for Dermatologic Diseases
- Leishmaniasis in a dog native to Colorado
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity
- Three Cases of Alopecia Following Clinical Islet Transplantation
- Non-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
- The therapeutic, diagnostic, and prognostic values of extracellular vesicles (exosomes) in dermatology: A systematic review
- Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor
- Skipping of Exons by Premature Termination of Transcription and Alternative Splicing within Intron-5 of the Sheep SCF Gene: A Novel Splice Variant
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- LEKTI: Netherton Syndrome and Atopic Dermatitis
- Bio-Nanovesicle-Based Approaches for Hair and Skin Regeneration: An Updated Concise Review
- Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response
- Hyaluronic Acid Profhilo® Alleviates Skin Inflammation and Spinal Neuroimmune Alterations in a Mouse Model of Atopic Dermatitis
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects